The huge strides made by Tencent Investment since 2015 are largely the result of its increased appetite for dealmaking on a grand scale as well as its willingness to look outside of China for new ventures.
Category: Analysis
Asia’s rise cemented in Global Corporate Venturing awards
The seventh annual Global Corporate Venturing awards are the first to be hosted in Hong Kong rather than London but reflect the changing face of the venture industry as it both globalises and scales up. From a US-dominated cottage industry of relatively small funds, the provision of innovation capital to fast-growing entrepreneurial businesses is being… Continue reading Asia’s rise cemented in Global Corporate Venturing awards
Big Deal: Nestlé bags Blue Bottle
When GV, the corporate venturing unit then known as Google Ventures, took part in upscale coffee brand Blue Bottle Coffee’s $20m series A round in 2012, it was seen by many as a vanity investment, but five years on, after the acquisition of a 68% stake by Nestlé, the deal looks a shrewd bet indeed.… Continue reading Big Deal: Nestlé bags Blue Bottle
Editorial: Update on GCV Rising Stars shows promotions and changes
For potential nominations to the 2018 GCV Rising Stars list, please contact me at jmawson@mawsonia.com
Analysis: 23andMe raises $250m
Genetics services company 23andMe, previously backed by Alphabet, Illumina, WuXi PharmaTech and Johnson and Johnson, secured a large $250m round.
The ins and outs of exits
A special report on the venture endgame
Brazil breezing through macro headwinds
Over the past few weeks and months, the country has seen positive headlines for large deals, venture fundraising and corporate innovation initiatives
Media sector grows while telecoms decelerates
Sector focus: Media
Moderate deal slowdown with record investments
The total number of corporate-backed deals in July and August stood at 360 – 192 of them took place in July and 168 in August, both slightly up from the 185 and 151 funding rounds in the same months last year. Investment values were even larger than last year’s levels. An estimated $9.13bn was invested… Continue reading Moderate deal slowdown with record investments
Analysis: NeoTract to be acquired for $1.1bn
Medical device producer NeoTract has agreed to be acquired by Teleflex for $1.1bn, giving an exit to Johnson & Johnson, a notable deal in a field where corporate commitments have been on the rise.
Editorial: Expedia CEO’s move to Uber follows venture successes
Following on from successes, such as eLong in China, and Expedia’s former CEO Dara has a storied track record in using tools to keep its global edge.
Big Deal: SoftBank Vision Fund goes big
Vision Fund’s $2.5bn investment in Flipkart last week, together with its huge bets on Fanatics and Roivant, could indicate where it plans to invest in the longer term.
Editorial: Sports venturing offers the brave a way to swim in money
It is, as these deals in the past week show, a remarkable time in sports and content as the change in distribution routes also affects the $40bn advertising industry.
Big Deal: Bristol-Myers Squibb tunes into IFM
The pharmaceutical company’s acquisition of Novartis-backed IFM Therapeutics, consisting of $300m upfront and up to $2bn in milestone payments, is its fourth purchase of a CVC-backed company in under four years.